# DESCRIPTION

## BACKGROUND OF THE INVENTION

### 1. Field of the Invention

- relate to method and kit for evaluating prognosis in patient with breast cancer

### 2. The Prior Art

- describe limitations of existing methods for evaluating prognosis in breast cancer

## SUMMARY OF THE INVENTION

- provide method for evaluating prognosis in patient with breast cancer
- describe kit for evaluating prognosis in patient with breast cancer
- summarize advantages of present invention

## DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

- define terms used in present invention

### Definition

- define data representation and experimental values

### High Expression of Pyruvate Kinase Isoenzyme M2 (PKM2) is Associated With Poor Clinical Outcome in Luminal Breast Cancer

- describe experimental design and methods
- present results of experiment

### High Expression of O-Linked Î²-N-Acetylglucosamine (O-GlcNAc) and PKM2 Can Predict Poor Prognosis of HR+/HER2- Breast Cancer

- describe experimental design and methods
- present results of experiment
- describe IHC assessment procedure
- present results of Kaplan-Meier analysis
- describe association of O-GlcNAc and PKM2 with recurrence
- present results of survival analysis

### Logistic Regression and Receiver Operating Characteristic (ROC) Curve Analysis

- describe logistic regression analysis
- present results of ROC curve analysis

